These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9156411

  • 1. Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins.
    Pini M.
    Semin Thromb Hemost; 1997; 23(1):51-4. PubMed ID: 9156411
    [Abstract] [Full Text] [Related]

  • 2. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A.
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [Abstract] [Full Text] [Related]

  • 3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Jan; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 4. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 5. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.
    Semin Thromb Hemost; 1997 Aug; 23(1):83-90. PubMed ID: 9156415
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 8. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F, Escribá A, Maluenda MP, López Rubio M, Margalet I, Lezana A, Gallego J, Ribera JM.
    Thromb Haemost; 2000 Oct 30; 84(4):559-64. PubMed ID: 11057850
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
    Holmström M, Aberg W, Lockner D, Paul C.
    Thromb Haemost; 1999 Oct 30; 82(4):1222-6. PubMed ID: 10544902
    [Abstract] [Full Text] [Related]

  • 12. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M, Lafoz E, Olive A, del Rio L, Vedia C.
    Thromb Haemost; 1994 Jan 30; 71(1):7-11. PubMed ID: 8165649
    [Abstract] [Full Text] [Related]

  • 13. Treatment of deep vein thrombosis with low-molecular-weight heparins: a consensus statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH).
    Harenberg J, Schmitz-Huebner U, Breddin KH, Hass S, Heinrich F, Heinrichs C, Kienast J, Roebruck P, Theiss W, Wenzel E.
    Semin Thromb Hemost; 1997 Jan 30; 23(1):91-6. PubMed ID: 9156416
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF, Matheny SC.
    Am Fam Physician; 1999 Feb 15; 59(4):945-52. PubMed ID: 10068716
    [Abstract] [Full Text] [Related]

  • 16. The role of low molecular weight heparin in total knee arthroplasty.
    Iobst CA, Friedman RJ.
    Am J Knee Surg; 1999 Feb 15; 12(1):55-60. PubMed ID: 10050695
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN.
    Bull Acad Natl Med; 1997 May 15; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [Abstract] [Full Text] [Related]

  • 18. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL, Perkins RB, Littell RD, Krasner CN, Duska LR.
    Obstet Gynecol; 2005 May 15; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.